{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:15:39Z","timestamp":1792905339220,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The polycystic ovarian syndrome (PCOS) is closely associated with enhanced apoptosis of granulosa cells, which have a vital role in maturation of oocytes. p53 plays a critical role in the regulation of apoptosis and cell cycle arrest, metabolism and insulin resistance. The aim of this study was to investigate the impact of p53 pathway in enhancing apoptosis and abnormal function of granulosa cells. In this study, microarray analysis and RNA sequencing were downloaded from the GEO and used as datasets. Principal Component Analysis (PCA) and online SSizer tool were applied to evaluate the experiment quality control and sample sufficiency, respectively. Bioinformatics\u2019 analyses were performed on the selected datasets, and validated by qRT-PCR and western blot analyses. Three datasets out of five ones were chosen for re-analyzing based on the PCA outcomes. 21 deregulated genes were identified via filters including\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090\n                    <jats:italic>.<\/jats:italic>\n                    05 and |log2FC|\u2265\u20091. Functional enrichment analysis confirmed the relevance of cell cycle regulation and apoptosis as common biological hallmarks in PCOS. Results have shown differentially expressed p53 target genes involved in apoptosis (\n                    <jats:italic>BAX, FAS, PMAIP1,<\/jats:italic>\n                    and\n                    <jats:italic>CASP8<\/jats:italic>\n                    ), cell cycle (Cyclins, Cyclin dependent kinases), glucose metabolism and insulin resistance (\n                    <jats:italic>THBS1<\/jats:italic>\n                    ), and p53 regulation (\n                    <jats:italic>MDM2<\/jats:italic>\n                    ). Subsequently, the relative mRNA expression of\n                    <jats:italic>FAS<\/jats:italic>\n                    ,\n                    <jats:italic>PMAIP1<\/jats:italic>\n                    and\n                    <jats:italic>MDM2<\/jats:italic>\n                    genes, and protein levels of p53 and MDM2 were confirmed using granulosa cells collected from 20 PCOS women and 18 control individuals by qRT-PCR and western blot, respectively. Results of this study represent the possible role of p53 pathway in pathogenesis of PCOS particularly, through the enhancement of apoptosis in granulosa cells.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-38340-1","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T07:09:52Z","timestamp":1689750592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Evaluation of the p53 pathway in polycystic ovarian syndrome pathogenesis and apoptosis enhancement in human granulosa cells through transcriptome data analysis"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5946-0998","authenticated-orcid":false,"given":"M.","family":"Zanjirband","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hodayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Safaeinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1983-3435","authenticated-orcid":false,"given":"M. H.","family":"Nasr-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ghaedi-Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"38340_CR1","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.endmts.2021.100085","volume":"3","author":"J Bulsara","year":"2021","unstructured":"Bulsara, J., Patel, P., Soni, A. & Acharya, S. A review: Brief insight into Polycystic Ovarian syndrome. Endocrine Metab. Sci. 3, 100085. https:\/\/doi.org\/10.1016\/j.endmts.2021.100085 (2021).","journal-title":"Endocrine Metab. Sci."},{"key":"38340_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/19396368.2016.1197982","volume":"62","author":"M Kori","year":"2016","unstructured":"Kori, M., Gov, E. & Arga, K. Y. Molecular signatures of ovarian diseases: Insights from network medicine perspective. Syst. Biol. Reprod. Med. 62, 266\u2013282. https:\/\/doi.org\/10.1080\/19396368.2016.1197982 (2016).","journal-title":"Syst. Biol. Reprod. Med."},{"key":"38340_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00396","author":"L Qi","year":"2020","unstructured":"Qi, L. et al. Single-cell transcriptomic analysis reveals mitochondrial dynamics in oocytes of patients with polycystic ovary syndrome. Front. Genet. https:\/\/doi.org\/10.3389\/fgene.2020.00396 (2020).","journal-title":"Front. Genet."},{"key":"38340_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/molehr\/gan082","volume":"15","author":"S Kenigsberg","year":"2009","unstructured":"Kenigsberg, S. et al. Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Mol. Hum. Reprod. 15, 89\u2013103. https:\/\/doi.org\/10.1093\/molehr\/gan082 (2009).","journal-title":"Mol. Hum. Reprod."},{"key":"38340_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106601","author":"M Zanjirband","year":"2023","unstructured":"Zanjirband, M., Safaeinejad, Z. & Nasr-Esfahani, M. H. Transcriptomic screening to identify hub genes and drug signatures for PCOS based on RNA-Seq data in granulosa cells. Comput. Biol. Med. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106601 (2023).","journal-title":"Comput. Biol. Med."},{"key":"38340_CR6","doi-asserted-by":"crossref","unstructured":"Strauss, J. F. & Williams, C. J. in Yen & Jaffe's Reproductive Endocrinology (Seventh Edition) (eds Jerome F. Strauss & Robert L. Barbieri) 157\u2013191.e158 (W.B. Saunders, 2014).","DOI":"10.1016\/B978-1-4557-2758-2.00009-3"},{"key":"38340_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00174","author":"J Tu","year":"2019","unstructured":"Tu, J., Cheung, A.H.-H., Chan, C.L.-K. & Chan, W.-Y. The role of microRNAs in ovarian granulosa cells in health and disease. Front. Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2019.00174 (2019).","journal-title":"Front. Endocrinol."},{"key":"38340_CR8","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1007\/s11033-020-05452-0","volume":"47","author":"A Raei Sadigh","year":"2020","unstructured":"Raei Sadigh, A. et al. Fractalkine and apoptotic\/anti-apoptotic markers in granulosa cells of women with polycystic ovarian syndrome. Mol. Biol. Rep. 47, 3593\u20133603. https:\/\/doi.org\/10.1007\/s11033-020-05452-0 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"38340_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng, X., Xie, Y. J., Liu, Y. T., Long, S. L. & Mo, Z. C. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin. Chim. Acta 502, 214\u2013221. https:\/\/doi.org\/10.1016\/j.cca.2019.11.003 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"38340_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2174\/1389450120666190402120701","volume":"20","author":"M Zanjirband","year":"2019","unstructured":"Zanjirband, M. & Rahgozar, S. Targeting p53-MDM2 interaction using small molecule inhibitors and the challenges needed to be addressed. Curr. Drug Targets 20, 1091\u20131111. https:\/\/doi.org\/10.2174\/1389450120666190402120701 (2019).","journal-title":"Curr. Drug Targets"},{"key":"38340_CR11","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1530\/joe-16-0324","volume":"231","author":"CP Kung","year":"2016","unstructured":"Kung, C. P. & Murphy, M. E. The role of the p53 tumor suppressor in metabolism and diabetes. J. Endocrinol. 231, R61-r75. https:\/\/doi.org\/10.1530\/joe-16-0324 (2016).","journal-title":"J. Endocrinol."},{"key":"38340_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00374","author":"M Charni-Natan","year":"2019","unstructured":"Charni-Natan, M., Aloni-Grinstein, R., Osher, E. & Rotter, V. Liver and steroid hormones\u2014Can a touch of p53 make a difference?. Front. Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2019.00374 (2019).","journal-title":"Front. Endocrinol."},{"key":"38340_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, 90. https:\/\/doi.org\/10.1002\/cpz1.90 (2021).","journal-title":"Curr. Protoc."},{"key":"38340_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fendo.2018.00061","volume":"9","author":"SLP Regan","year":"2018","unstructured":"Regan, S. L. P. et al. Granulosa cell apoptosis in the ovarian follicle\u2014A changing view. Front. Endocrinol. 9, 61. https:\/\/doi.org\/10.3389\/fendo.2018.00061 (2018).","journal-title":"Front. Endocrinol."},{"key":"38340_CR15","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1096\/fj.201801401R","volume":"33","author":"H Haraguchi","year":"2019","unstructured":"Haraguchi, H. et al. Mdm2-p53-SF1 pathway in ovarian granulosa cells directs ovulation and fertilization by conditioning oocyte quality. FASEB J. 33, 2610\u20132620. https:\/\/doi.org\/10.1096\/fj.201801401R (2019).","journal-title":"FASEB J."},{"key":"38340_CR16","doi-asserted-by":"publisher","first-page":"10470","DOI":"10.1038\/s41598-022-14708-7","volume":"12","author":"H Safari","year":"2022","unstructured":"Safari, H., Hajian, M., Nasr-Esfahani, M. H., Forouzanfar, M. & Drevet, J. R. Vitamin D and calcium, together and separately, play roles in female reproductive performance. Sci. Rep. 12, 10470. https:\/\/doi.org\/10.1038\/s41598-022-14708-7 (2022).","journal-title":"Sci. Rep."},{"key":"38340_CR17","doi-asserted-by":"publisher","first-page":"105521","DOI":"10.1016\/j.jsbmb.2019.105521","volume":"197","author":"F Masjedi","year":"2020","unstructured":"Masjedi, F. et al. Effects of vitamin D on steroidogenesis, reactive oxygen species production, and enzymatic antioxidant defense in human granulosa cells of normal and polycystic ovaries. J. Steroid Biochem. Mol. Biol. 197, 105521. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105521 (2020).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"38340_CR18","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: Archive for functional genomics data sets\u2013update. Nucleic Acids Res. 41, D991\u2013D995. https:\/\/doi.org\/10.1093\/nar\/gks1193 (2013).","journal-title":"Nucleic Acids Res."},{"key":"38340_CR19","doi-asserted-by":"publisher","first-page":"E2016","DOI":"10.1210\/jc.2011-3441","volume":"97","author":"S Kaur","year":"2012","unstructured":"Kaur, S. et al. Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis. J. Clin. Endocrinol. Metab. 97, E2016\u2013E2021. https:\/\/doi.org\/10.1210\/jc.2011-3441 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"38340_CR20","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.18632\/aging.202421","volume":"13","author":"M Tan","year":"2021","unstructured":"Tan, M. et al. LNK promotes granulosa cell apoptosis in PCOS via negatively regulating insulin-stimulated AKT-FOXO3 pathway. Aging (Albany NY) 13, 4617\u20134633. https:\/\/doi.org\/10.18632\/aging.202421 (2021).","journal-title":"Aging (Albany NY)"},{"key":"38340_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.omtn.2020.12.008","volume":"23","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome. Mol. Therapy Nucleic Acids 23, 614\u2013628. https:\/\/doi.org\/10.1016\/j.omtn.2020.12.008 (2021).","journal-title":"Mol. Therapy Nucleic Acids"},{"key":"38340_CR22","doi-asserted-by":"publisher","first-page":"8231","DOI":"10.3892\/mmr.2017.7658","volume":"16","author":"X Cui","year":"2017","unstructured":"Cui, X. et al. Abnormal expression levels of BMP15\/Smad1 are associated with granulosa cell apoptosis in patients with polycystic ovary syndrome. Mol. Med. Rep. 16, 8231\u20138236. https:\/\/doi.org\/10.3892\/mmr.2017.7658 (2017).","journal-title":"Mol. Med. Rep."},{"key":"38340_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"BJ Aubrey","year":"2018","unstructured":"Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J. & Strasser, A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?. Cell Death Differ. 25, 104\u2013113. https:\/\/doi.org\/10.1038\/cdd.2017.169 (2018).","journal-title":"Cell Death Differ."},{"key":"38340_CR24","doi-asserted-by":"publisher","first-page":"26104","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen, J. The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring. Harb. Perspect. Med. 6, 26104. https:\/\/doi.org\/10.1101\/cshperspect.a026104 (2016).","journal-title":"Cold Spring. Harb. Perspect. Med."},{"key":"38340_CR25","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.3390\/cancers13133257","volume":"13","author":"A Lees","year":"2021","unstructured":"Lees, A., Sessler, T. & McDade, S. Dying to survive\u2014The p53 Paradox. Cancers 13, 3257 (2021).","journal-title":"Cancers"},{"key":"38340_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jmcb\/mjy070","volume":"11","author":"J Liu","year":"2019","unstructured":"Liu, J., Zhang, C., Hu, W. & Feng, Z. Tumor suppressor p53 and metabolism. J. Mol. Cell. Biol. 11, 284\u2013292. https:\/\/doi.org\/10.1093\/jmcb\/mjy070 (2019).","journal-title":"J. Mol. Cell. Biol."},{"key":"38340_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2164-9-124","volume":"9","author":"P Pedotti","year":"2008","unstructured":"Pedotti, P. et al. Can subtle changes in gene expression be consistently detected with different microarray platforms?. BMC Genom. 9, 124. https:\/\/doi.org\/10.1186\/1471-2164-9-124 (2008).","journal-title":"BMC Genom."},{"key":"38340_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot, D., Latz, E. & Franklin, B. S. Necroptosis, pyroptosis and apoptosis: An intricate game of cell death. Cell. Mol. Immunol. 18, 1106\u20131121. https:\/\/doi.org\/10.1038\/s41423-020-00630-3 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"38340_CR29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1590\/1519-6984.228437","volume":"81","author":"E Obeng","year":"2021","unstructured":"Obeng, E. Apoptosis (programmed cell death) and its signals\u2014A review. Braz. J. Biol. 81, 1133\u20131143. https:\/\/doi.org\/10.1590\/1519-6984.228437 (2021).","journal-title":"Braz. J. Biol."},{"key":"38340_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jgyn.2015.08.013","volume":"46","author":"XQ Wu","year":"2017","unstructured":"Wu, X. Q. et al. The WNT\/\u03b2-catenin signaling pathway may be involved in granulosa cell apoptosis from patients with PCOS in North China. J. Gynecol. Obstet. Hum. Reprod. 46, 93\u201399. https:\/\/doi.org\/10.1016\/j.jgyn.2015.08.013 (2017).","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"38340_CR31","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3892\/mmr.2018.9793","volume":"19","author":"R Yang","year":"2019","unstructured":"Yang, R., Chen, J., Wang, L. & Deng, A. LncRNA BANCR participates in polycystic ovary syndrome by promoting cell apoptosis. Mol. Med. Rep. 19, 1581\u20131586. https:\/\/doi.org\/10.3892\/mmr.2018.9793 (2019).","journal-title":"Mol. Med. Rep."},{"key":"38340_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejogrb.2013.09.026","volume":"171","author":"KK Zhao","year":"2013","unstructured":"Zhao, K. K. et al. Effect of HSP10 on apoptosis induced by testosterone in cultured mouse ovarian granulosa cells. Eur. J. Obstet. Gynecol. Reprod. Biol. 171, 301\u2013306. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.09.026 (2013).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"38340_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/hmg\/10.3.237","volume":"10","author":"L Weng","year":"2001","unstructured":"Weng, L., Brown, J. & Eng, C. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase\/Akt-dependent and -independent pathways. Hum. Mol. Genet. 10, 237\u2013242. https:\/\/doi.org\/10.1093\/hmg\/10.3.237 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"38340_CR34","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1016\/j.febslet.2011.08.031","volume":"585","author":"YC Tsai","year":"2011","unstructured":"Tsai, Y. C. & Weissman, A. M. Dissecting the diverse functions of the metastasis suppressor CD82\/KAI1. FEBS Lett. 585, 3166\u20133173. https:\/\/doi.org\/10.1016\/j.febslet.2011.08.031 (2011).","journal-title":"FEBS Lett."},{"key":"38340_CR35","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1038\/leu.2015.219","volume":"29","author":"C Nishioka","year":"2015","unstructured":"Nishioka, C. et al. The novel function of CD82 and its impact on BCL2L12 via AKT\/STAT5 signal pathway in acute myelogenous leukemia cells. Leukemia 29, 2296\u20132306. https:\/\/doi.org\/10.1038\/leu.2015.219 (2015).","journal-title":"Leukemia"},{"key":"38340_CR36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/molehr\/gap092","volume":"15","author":"D Adhikari","year":"2009","unstructured":"Adhikari, D. et al. Disruption of Tsc2 in oocytes leads to overactivation of the entire pool of primordial follicles. Mol. Hum. Reprod. 15, 765\u2013770. https:\/\/doi.org\/10.1093\/molehr\/gap092 (2009).","journal-title":"Mol. Hum. Reprod."},{"key":"38340_CR37","doi-asserted-by":"publisher","first-page":"9270549","DOI":"10.1155\/2017\/9270549","volume":"2017","author":"J Strycharz","year":"2017","unstructured":"Strycharz, J., Drzewoski, J., Szemraj, J. & Sliwinska, A. Is p53 involved in tissue-specific insulin resistance formation?. Oxid. Med. Cell. Longev. 2017, 9270549. https:\/\/doi.org\/10.1155\/2017\/9270549 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"38340_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fendo.2019.00374","volume":"10","author":"M Charni-Natan","year":"2019","unstructured":"Charni-Natan, M., Aloni-Grinstein, R., Osher, E. & Rotter, V. Liver and steroid hormones-can a touch of p53 make a difference?. Front. Endocrinol. 10, 374. https:\/\/doi.org\/10.3389\/fendo.2019.00374 (2019).","journal-title":"Front. Endocrinol."},{"key":"38340_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/mco.2018.1657","volume":"9","author":"EM Gordon","year":"2018","unstructured":"Gordon, E. M., Ravicz, J. R., Liu, S., Chawla, S. P. & Hall, F. L. Cell cycle checkpoint control: The cyclin G1\/Mdm2\/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy\u2014A review of molecular mechanisms for oncologists. Mol. Clin. Oncol. 9, 115\u2013134. https:\/\/doi.org\/10.3892\/mco.2018.1657 (2018).","journal-title":"Mol. Clin. Oncol."},{"key":"38340_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21061960","author":"L Ding","year":"2020","unstructured":"Ding, L. et al. The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21061960 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"38340_CR41","doi-asserted-by":"publisher","first-page":"649295","DOI":"10.3389\/fphys.2021.649295","volume":"12","author":"R Xu","year":"2021","unstructured":"Xu, R. & Wang, Z. Involvement of transcription factor FoxO1 in the pathogenesis of polycystic ovary syndrome. Front. Physiol. 12, 649295. https:\/\/doi.org\/10.3389\/fphys.2021.649295 (2021).","journal-title":"Front. Physiol."},{"key":"38340_CR42","doi-asserted-by":"publisher","first-page":"11152","DOI":"10.1016\/j.mce.2021.111528","volume":"543","author":"Y Li","year":"2022","unstructured":"Li, Y., Xiang, Y., Song, Y., Zhang, D. & Tan, L. MALAT1 downregulation is associated with polycystic ovary syndrome via binding with MDM2 and repressing P53 degradation. Mol. Cell. Endocrinol. 543, 11152. https:\/\/doi.org\/10.1016\/j.mce.2021.111528 (2022).","journal-title":"Mol. Cell. Endocrinol."},{"key":"38340_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4267\/2042\/70774","volume":"24","author":"JS Isenberg","year":"2020","unstructured":"Isenberg, J. S. & Roberts, D. D. THBS1 (thrombospondin-1). Atlas Genet. Cytogenet. Oncol. Haematol. 24, 291\u2013299. https:\/\/doi.org\/10.4267\/2042\/70774 (2020).","journal-title":"Atlas Genet. Cytogenet. Oncol. Haematol."},{"key":"38340_CR44","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.metabol.2015.07.016","volume":"64","author":"Y Matsuo","year":"2015","unstructured":"Matsuo, Y. et al. Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome. Metabolism 64, 1490\u20131499. https:\/\/doi.org\/10.1016\/j.metabol.2015.07.016 (2015).","journal-title":"Metabolism"},{"key":"38340_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102849","author":"J Bai","year":"2020","unstructured":"Bai, J. et al. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans. EBioMedicine https:\/\/doi.org\/10.1016\/j.ebiom.2020.102849 (2020).","journal-title":"EBioMedicine"},{"key":"38340_CR46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3389\/fendo.2019.00727","volume":"10","author":"HR Bender","year":"2019","unstructured":"Bender, H. R., Campbell, G. E., Aytoda, P., Mathiesen, A. H. & Duffy, D. M. Thrombospondin 1 (THBS1) promotes follicular angiogenesis, luteinization, and ovulation in primates. Front. Endocrinol. 10, 727\u2013727. https:\/\/doi.org\/10.3389\/fendo.2019.00727 (2019).","journal-title":"Front. Endocrinol."},{"key":"38340_CR47","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3390\/cells10061396","volume":"10","author":"C Dompe","year":"2021","unstructured":"Dompe, C. et al. Human granulosa cells\u2014Stemness properties, molecular cross-talk follicular angiogenesis. Cells 10, 1396 (2021).","journal-title":"Cells"},{"key":"38340_CR48","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1210\/en.2009-0686","volume":"151","author":"SA Garside","year":"2010","unstructured":"Garside, S. A., Harlow, C. R., Hillier, S. G., Fraser, H. M. & Thomas, F. H. Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay. Endocrinology 151, 1280\u20131289. https:\/\/doi.org\/10.1210\/en.2009-0686 (2010).","journal-title":"Endocrinology"},{"key":"38340_CR49","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.omtn.2020.11.005","volume":"23","author":"L Bai","year":"2021","unstructured":"Bai, L. et al. Aberrant elevation of GDF8 impairs granulosa cell glucose metabolism via upregulating SERPINE1 expression in patients with PCOS. Mol. Ther. Nucleic Acids 23, 294\u2013309. https:\/\/doi.org\/10.1016\/j.omtn.2020.11.005 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"38340_CR50","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1016\/j.cellsig.2020.109702","volume":"73","author":"X Qu","year":"2020","unstructured":"Qu, X. et al. TNF\u03b1-Erk1\/2 signaling pathway-regulated SerpinE1 and SerpinB2 are involved in lipopolysaccharide-induced porcine granulosa cell proliferation. Cell. Signalling 73, 10970. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109702 (2020).","journal-title":"Cell. Signalling"},{"key":"38340_CR51","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/mrd.21202","volume":"77","author":"P Lin","year":"2010","unstructured":"Lin, P. & Rui, R. Effects of follicular size and FSH on granulosa cell apoptosis and atresia in porcine antral follicles. Mol. Reprod. Dev. 77, 670\u2013678. https:\/\/doi.org\/10.1002\/mrd.21202 (2010).","journal-title":"Mol. Reprod. Dev."},{"key":"38340_CR52","doi-asserted-by":"publisher","first-page":"e1475","DOI":"10.1038\/cddis.2014.400","volume":"5","author":"M Shen","year":"2014","unstructured":"Shen, M. et al. Involvement of FoxO1 in the effects of follicle-stimulating hormone on inhibition of apoptosis in mouse granulosa cells. Cell Death Dis. 5, e1475\u2013e1475. https:\/\/doi.org\/10.1038\/cddis.2014.400 (2014).","journal-title":"Cell Death Dis."},{"key":"38340_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1677\/joe.1.06087","volume":"188","author":"KA Slot","year":"2006","unstructured":"Slot, K. A. et al. Luteinizing hormone inhibits Fas-induced apoptosis in ovarian surface epithelial cell lines. J. Endocrinol. 188, 227\u2013239. https:\/\/doi.org\/10.1677\/joe.1.06087 (2006).","journal-title":"J. Endocrinol."},{"key":"38340_CR54","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/labinvest.2011.116","volume":"91","author":"M Anttonen","year":"2011","unstructured":"Anttonen, M. et al. Anti-M\u00fcllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis. Lab. Investig. 91, 1605\u20131614. https:\/\/doi.org\/10.1038\/labinvest.2011.116 (2011).","journal-title":"Lab. Investig."},{"key":"38340_CR55","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/humrep\/deac204","volume":"37","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. Anti-M\u00fcllerian hormone-mediated preantral follicle atresia is a key determinant of antral follicle count in mice. Hum. Reprod. 37, 2635\u20132645. https:\/\/doi.org\/10.1093\/humrep\/deac204 (2022).","journal-title":"Hum. Reprod."},{"key":"38340_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43043-021-00071-6","volume":"26","author":"S Salama","year":"2021","unstructured":"Salama, S. et al. FSH versus AMH: Age-related relevance to ICSI results. Middle East Fertil. Soc. J. 26, 27. https:\/\/doi.org\/10.1186\/s43043-021-00071-6 (2021).","journal-title":"Middle East Fertil. Soc. J."},{"key":"38340_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.fertnstert.2019.03.022","volume":"112","author":"S Ligon","year":"2019","unstructured":"Ligon, S., Lustik, M., Levy, G. & Pier, B. Low antim\u00fcllerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle-stimulating hormone and AMH are discordant. Fertil. Steril. 112, 73-81.e71. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.03.022 (2019).","journal-title":"Fertil. Steril."},{"key":"38340_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.07.1421","author":"HAY Thum","year":"2008","unstructured":"Thum, H. A. Y. Association of AMH and FSH levels with IVF treatment outcome. Fertil. Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.07.1421 (2008).","journal-title":"Fertil. Steril."},{"key":"38340_CR59","doi-asserted-by":"crossref","unstructured":"Abu el Maaty, M. A. & W\u00f6lfl, S. Vitamin D as a novel regulator of tumor metabolism: Insights on potential mechanisms and implications for anti-cancer therapy. Int. J. Mol. Sci 18, 2184 (2017).","DOI":"10.3390\/ijms18102184"},{"key":"38340_CR60","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1167\/iovs.02-1198","volume":"44","author":"I Audo","year":"2003","unstructured":"Audo, I. et al. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Investig. Ophthalmol. Vis. Sci. 44, 4192\u20134199. https:\/\/doi.org\/10.1167\/iovs.02-1198 (2003).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"38340_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"R. E. A.-S. P. C. W","year":"2004","unstructured":"Group & R. E. A.-S. P. C. W,. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004 (2004).","journal-title":"Fertil. Steril."},{"key":"38340_CR62","doi-asserted-by":"publisher","first-page":"012003","DOI":"10.1088\/1742-6596\/705\/1\/012003","volume":"705","author":"GA Merino","year":"2016","unstructured":"Merino, G. A. et al. The impact of quality control in RNA-seq experiments. J. Phys. Conf. Ser. 705, 012003. https:\/\/doi.org\/10.1088\/1742-6596\/705\/1\/012003 (2016).","journal-title":"J. Phys. Conf. Ser."},{"key":"38340_CR63","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.jmb.2020.01.027","volume":"432","author":"F Li","year":"2020","unstructured":"Li, F. et al. SSizer: Determining the sample sufficiency for comparative biological study. J. Mol. Biol. 432, 3411\u20133421 (2020).","journal-title":"J. Mol. Biol."},{"key":"38340_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy\u2014Analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315. https:\/\/doi.org\/10.1093\/bioinformatics\/btg405 (2004).","journal-title":"Bioinformatics"},{"key":"38340_CR65","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res."},{"key":"38340_CR66","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"key":"38340_CR67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle, H., Meirelles, G. V., da Silva, F. R., Telles, G. P. & Minghim, R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinf. 16, 169. https:\/\/doi.org\/10.1186\/s12859-015-0611-3 (2015).","journal-title":"BMC Bioinf."},{"key":"38340_CR68","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377 (2016).","journal-title":"Nucleic Acids Res."},{"key":"38340_CR69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/humrep\/dew287","volume":"32","author":"R Wang","year":"2017","unstructured":"Wang, R. & Mol, B. W. J. The Rotterdam criteria for polycystic ovary syndrome: Evidence-based criteria?. Hum. Reprod. 32, 261\u2013264. https:\/\/doi.org\/10.1093\/humrep\/dew287 (2017).","journal-title":"Hum. Reprod."},{"key":"38340_CR70","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/2277-9175.170675","volume":"4","author":"E Aghadavod","year":"2015","unstructured":"Aghadavod, E. et al. Isolation of granulosa cells from follicular fluid; applications in biomedical and molecular biology experiments. Adv. Biomed. Res. 4, 250. https:\/\/doi.org\/10.4103\/2277-9175.170675 (2015).","journal-title":"Adv. Biomed. Res."},{"key":"38340_CR71","doi-asserted-by":"publisher","unstructured":"Maryam, Z., Soheila, R. & Narges, A. miR-16\u20135p enhances sensitivity to RG7388 through targeting <i>PPM1D<\/i> expression (WIP1) in Childhood Acute Lymphoblastic Leukemia. miR-16\u20135p enhances sensitivity to RG7388 through targeting <i>PPM1D<\/i> expression (WIP1) in Childhood Acute Lymphoblastic Leukemia 6, 242\u2013256. https:\/\/doi.org\/10.20517\/cdr.2022.113 (2023).","DOI":"10.20517\/cdr.2022.113"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38340-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T07:16:19Z","timestamp":1689750979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38340-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38340"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38340-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11648"}}